HGD and alkaptonuria: Being an inhibitor of 4-HPPD, an upstream enzyme compared to HGD in the catabolic pathway of tyrosine [5], nitisinone (NTBC) became the first approved drug for AKU thanks to its efficacy in lowering HGA levels in affected individuals [6].